A Phase II Study of Thiotepa Added to Fludarabine and Melphalan as the Preparative Regime for Alternative Donor Transplantation
Phase of Trial: Phase II
Latest Information Update: 15 Dec 2018
At a glance
- Drugs Thiotepa (Primary) ; Fludarabine; Melphalan
- Indications Acute myeloid leukaemia; Chronic myeloid leukaemia; Lymphoid leukaemia; Myelodysplastic syndromes; Myelofibrosis; Precursor cell lymphoblastic leukaemia-lymphoma
- Focus Therapeutic Use
- 31 Aug 2018 Biomarkers information updated
- 21 May 2018 Status changed from not yet recruiting to recruiting.
- 02 Feb 2018 Planned initiation date changed from 31 Dec 2017 to 1 Aug 2018.